InMode Ltd. Share Price

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 01:30:00 18/05/2024 am IST Pre-market 05:30:29 pm
18.46 USD -0.97% Intraday chart for InMode Ltd. 18.65 +1.03%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 480M 39.98B Sales 2025 * 520M 43.32B Capitalization 1.56B 130B
Net income 2024 * 165M 13.74B Net income 2025 * 189M 15.74B EV / Sales 2024 * 1.24 x
Net cash position 2024 * 968M 80.57B Net cash position 2025 * 1.19B 98.87B EV / Sales 2025 * 0.72 x
P/E ratio 2024 *
9.54 x
P/E ratio 2025 *
8.44 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.03%
1 week+1.99%
Current month+7.39%
1 month+6.03%
3 months-19.04%
6 months-16.43%
Current year-17.00%
More quotes
1 week
18.44
Extreme 18.435
19.05
1 month
16.72
Extreme 16.72
19.05
Current year
16.72
Extreme 16.72
26.80
1 year
16.72
Extreme 16.72
48.25
3 years
16.72
Extreme 16.72
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 02/08/02
Chief Executive Officer 71 02/08/02
Director of Finance/CFO 46 01/17/01
Members of the board TitleAgeSince
Director/Board Member 89 07/19/07
Chief Executive Officer 71 02/08/02
Founder 57 02/08/02
More insiders
Date Price Change Volume
17/24/17 18.46 -0.97% 786,082
16/24/16 18.64 -1.11% 1,024,614
15/24/15 18.85 +1.45% 1,190,342
14/24/14 18.58 +0.49% 978,212
13/24/13 18.49 +2.15% 937,939

Delayed Quote Nasdaq, May 18, 2024 at 01:30 am IST

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.46 USD
Average target price
25.6 USD
Spread / Average Target
+38.68%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW